Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV
This study is ongoing, but not recruiting participants.
Study NCT00080119 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: March 23, 2004 Last Updated: November 19, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Tuberculosis
Pneumocystis Jirovecii Pneumonia
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Communicable Diseases
Infection
Pneumonia
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Lung Diseases
Mycobacterium Infections
Respiratory Tract Diseases
Respiratory Tract Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Isoniazid
Sulfamethoxazole/Trimethoprim
Additional drug interventions recognized in this trial
Sulfamethoxazole
Trimethoprim
Trimethoprim-Sulfamethoxazole Combination
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Antilipemic Agents
Antimalarials
Antimetabolites
Antiparasitic Agents
Antiprotozoal Agents
Antitubercular Agents
Enzyme Inhibitors
Fatty Acid Synthesis Inhibitors
Folic Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Renal Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Comprehensive International Program of Research on AIDS
Secure the Future Foundation
Back to top of Main Content
